The purpose of this study is to evaluate the safety and effectiveness of an investigational, oral drug for celiac disease to see if it can reduce the symptoms of celiac disease (such as abdominal pain, diarrhea, bloating, cramping, and gas) as compared to a placebo.
Duration: Approximately 4 1/2 months
Number of visits to AMR Lexington: 7
Reimbursement: Up to $640.00 for time and travel.
NOTE: Qualified participants must be at least 18 years of age, have been formally diagnosed by a physician as having celiac disease, have had celiac disease for at least the past 6 months, and have followed a gluten-free diet for at least 6 consecutive months. Other criteria also apply.